CEO Novapeutics

Frank Leu is a co-founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for the type 2 diabetes. Prior, Frank was at a specialty pharma, Verto Institute, developing antibody therapeutics for neuroendocrine cancer. Frank holds a doctorate degree in Pharmacology from the Weill Cornell Graduate School of Medical Sciences, and performed his posdoctoral work at a Howard Hughes Medical Institute lab at the Rockefeller University. Frank also founded BioPharMatrix, an advisory firm providing pragmatic vision and intelligence in the area of lifesciences; such as working with the 1776 (formerly Benjamins Desk) on shaping, developing and running of the Pennovation Center’s biopharma laboratories at the University of Pennsylvania.

Check out the incredible speaker line-up to see who will be joining FRANK.

Download The Latest Agenda